Pro Medicus has reported a 28% revenue growth on a constant currency basis, with A$407M in new contracts and A$1.3B in forward contracts. The company's revenue reached A$261.7 million, representing a 22.9% reported growth and 28.4% constant currency growth.
Financial Highlights
The company's underlying EBIT increased to A$196.1 million, up 24.4% on a reported basis and 30.6% in constant currency terms. EBIT margins expanded to 74.9%, an increase of 90 basis points year-over-year.
Contract Wins
Pro Medicus signed 10 new contracts worth A$407 million during FY26, including a A$170 million contract with UCHealth Colorado and a A$90 million contract with Beth Israel Lahey Health. The company also reported a 100% renewal rate, with all six contracts up for renewal being extended for five-year terms at higher per-transaction fees.
Forward Contracts
Forward contracts of A$1.34 billion over the next five years represent a 41.3% increase in just 12 months, providing substantial revenue visibility. The 29% CAGR in forward contracts underscores growing demand for the company's Visage 7 platform and cloud-based solutions.